CID 11234052

Brivanib

Structural Information

Molecular Formula
C19H19FN4O3
SMILES
CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C
InChI
InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1
InChIKey
WCWUXEGQKLTGDX-LLVKDONJSA-N
Compound name
(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

93
References

6115
Patents

370.1441 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 371.15138 186.6
[M+Na]+ 393.13332 198.9
[M-H]- 369.13682 188.7
[M+NH4]+ 388.17792 198.5
[M+K]+ 409.10726 192.4
[M+H-H2O]+ 353.14136 177.1
[M+HCOO]- 415.14230 203.2
[M+CH3COO]- 429.15795 196.8
[M+Na-2H]- 391.11877 187.0
[M]+ 370.14355 192.9
[M]- 370.14465 192.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe